(19)
(11) EP 2 802 308 A1

(12)

(43) Date of publication:
19.11.2014 Bulletin 2014/47

(21) Application number: 13701534.3

(22) Date of filing: 11.01.2013
(51) International Patent Classification (IPC): 
A61K 8/65(2006.01)
A61Q 19/00(2006.01)
A61L 27/52(2006.01)
A61K 8/73(2006.01)
A61Q 19/08(2006.01)
(86) International application number:
PCT/US2013/021243
(87) International publication number:
WO 2013/106715 (18.07.2013 Gazette 2013/29)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 13.01.2012 US 201261586589 P
04.09.2012 US 201213603213
06.09.2012 US 201213605565
02.11.2012 US 201213667581
27.12.2012 US 201213728855

(71) Applicant: ALLERGAN, INC.
Irvine, CA 92612 (US)

(72) Inventors:
  • POLLOCK, Jacob F.
    Charleston, West Virginia 25314 (US)
  • CUI, Cunqi
    Goleta, California 93117 (US)
  • KOKAI, Lauren E.
    Goleta, California 93101 (US)
  • YU, Xiaojie
    Irvine, California 92602 (US)
  • VAN EPPS, Dennis E.
    Goleta, California 93117 (US)
  • MESSINA, Darin J.
    Santa Barbara, California 93101 (US)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) CROSSLINKED HYALURONIC ACID-COLLAGEN GELS FOR IMPROVING TISSUE GRAFT VIABILITY AND SOFT TISSUE AUGMENTATION